Colombia vs Slovak Republic: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Colombia
- Slovak Republic
How they compare
Colombia currently reports 14,169 Cases against 7 Cases in Slovak Republic, a difference of 14,162 Cases.
That makes Colombia's figure about 2,024.1 times Slovak Republic's.
Across all 11 years both countries report, Colombia has been ahead every year.
Colombia ranks 4th and Slovak Republic ranks 3rd of 34 countries.
Colombia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Colombia | Slovak Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8,517 Cases | 7.5 Cases | 8,510 Cases | Colombia |
| 2020s | 12,776 Cases | 4.8 Cases | 12,772 Cases | Colombia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Colombia or Slovak Republic?
- Colombia, at 14,169 Cases against 7 Cases in Slovak Republic as of 2025.
- What is the difference in communicable diseases — communicable disease incidence between Colombia and Slovak Republic?
- 14,162 Cases, with Colombia ahead.
- How many years of comparable data are there for Colombia and Slovak Republic?
- 11 years are reported by both, from 2014 to 2024.
- How do Colombia and Slovak Republic rank globally for communicable diseases — communicable disease incidence?
- Colombia ranks 4th and Slovak Republic ranks 3rd of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.